Breakthrough Chemistry, Inc. (BKTH)
0.208
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Breakthrough Chemistry Shareholders Equity (Quarterly) : 0.8373M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8373M |
| March 31, 2026 | 1.920M |
| December 31, 2025 | 1.841M |
| September 30, 2025 | 0.4391M |
| June 30, 2025 | 0.4588M |
| March 31, 2024 | 0.5197M |
| December 31, 2023 | 2.513M |
| September 30, 2023 | 2.994M |
| June 30, 2023 | 2.961M |
| March 31, 2023 | 0.6853M |
| December 31, 2022 | 0.6894M |
| September 30, 2022 | 0.2389M |
| June 30, 2022 | 0.1867M |
| March 31, 2022 | -0.2044M |
| December 31, 2021 | -0.1849M |
| September 30, 2021 | -0.1476M |
| June 30, 2021 | -0.0917M |
| March 31, 2021 | -0.0735M |
| December 31, 2020 | -0.2131M |
| September 30, 2020 | -0.2389M |
| June 30, 2020 | -41.61M |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | |
| October 31, 2018 |
| Date | Value |
|---|---|
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | |
| April 30, 2017 | |
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | 2.501M |
| July 31, 2014 | 2.297M |
| April 30, 2014 | 2.297M |
| January 31, 2014 | 2.297M |
| October 31, 2013 | 2.297M |
| July 31, 2013 | 2.297M |
| April 30, 2013 | 2.298M |
| January 31, 2013 | 2.297M |
| October 31, 2012 | 2.297M |
| July 31, 2012 | 2.297M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cardiac Biotech Solutions, Inc. | -2.221M |
| Precision Optics Corp., Inc. | 20.11M |
| Petros Pharmaceuticals, Inc. | 0.7009M |
| RxSight, Inc. | 263.34M |
| Vyome Holdings, Inc. | 6.048M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.300M |
| Total Liabilities (Quarterly) | 0.4631M |
| Debt to Equity Ratio | 0.2335 |
| Current Ratio | 3.450 |
| Net Debt Paydown Yield | 0.18% |